241 related articles for article (PubMed ID: 35696192)
1. Human leukocyte antigen-haploidentical transplantation for relapsed/refractory acute myeloid leukemia: Better leukemia-free survival with bone marrow than with peripheral blood stem cells in patients ≥55 years of age.
Baron F; Labopin M; Tischer J; Ciceri F; Raiola AM; Blaise D; Sica S; Vydra J; Fanin R; Stölzel F; Busca A; Diez-Martin JL; Koc Y; Nagler A; Mohty M
Am J Hematol; 2022 Aug; 97(8):1065-1074. PubMed ID: 35696192
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamide.
Ruggeri A; Labopin M; Bacigalupo A; Gülbas Z; Koc Y; Blaise D; Bruno B; Irrera G; Tischer J; Diez-Martin JL; Castagna L; Ciceri F; Mohty M; Nagler A
Cancer; 2018 Apr; 124(7):1428-1437. PubMed ID: 29360162
[TBL] [Abstract][Full Text] [Related]
3. Mobilized peripheral blood stem cells compared with bone marrow as the stem cell source for unrelated donor allogeneic transplantation with reduced-intensity conditioning in patients with acute myeloid leukemia in complete remission: an analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Nagler A; Labopin M; Shimoni A; Niederwieser D; Mufti GJ; Zander AR; Arnold R; Greinix H; Cornelissen JJ; Jackson GH; Craddock C; Bunjes DW; Ganser A; Russell NH; Kyrcz-Krzemien S; Rocha V; Mohty M
Biol Blood Marrow Transplant; 2012 Sep; 18(9):1422-9. PubMed ID: 22446014
[TBL] [Abstract][Full Text] [Related]
4. Advantages of peripheral blood stem cells from unrelated donors versus bone marrow transplants in outcomes of adult acute myeloid leukemia patients.
Jo T; Arai Y; Kondo T; Mizuno S; Hirabayashi S; Inamoto Y; Doki N; Fukuda T; Ozawa Y; Katayama Y; Kanda Y; Fukushima K; Matsuoka KI; Takada S; Sawa M; Ashida T; Onizuka M; Ichinohe T; Atsuta Y; Kanda J; Yanada M
Cytotherapy; 2022 Oct; 24(10):1013-1025. PubMed ID: 35729020
[TBL] [Abstract][Full Text] [Related]
5. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.
Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q
J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100
[TBL] [Abstract][Full Text] [Related]
6. Outcomes after Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide: A Systematic Review and Meta-Analysis Comparing Myeloablative with Reduced-Intensity Conditioning Regimens and Bone Marrow with Peripheral Blood Stem Cell Grafts.
Arcuri LJ; Hamerschlak N; Rocha V; Bonfim C; Kerbauy MN
Transplant Cell Ther; 2021 Sep; 27(9):782.e1-782.e7. PubMed ID: 34146733
[TBL] [Abstract][Full Text] [Related]
7. Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Nagler A; Labopin M; Houhou M; Aljurf M; Mousavi A; Hamladji RM; Al Zahrani M; Bondarenko S; Arat M; Angelucci E; Koc Y; Gülbas Z; Sica S; Bourhis JH; Canaani J; Brissot E; Giebel S; Mohty M
J Hematol Oncol; 2021 Apr; 14(1):53. PubMed ID: 33794963
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Outcomes after Unrelated Double-Unit Cord Blood and Haploidentical Peripheral Blood Stem Cell Transplantation in Adults with Acute Myelogenous Leukemia: A Study on Behalf of Eurocord and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Ruggeri A; Galimard JE; Labopin M; Rafii H; Blaise D; Ciceri F; Diez-Martin JL; Cornelissen J; Chevallier P; Sanchez-Guijo F; Nicholson E; Castagna L; Forcade E; Kuball J; Rovira M; Koc Y; Pavlu J; Gulbas Z; Vydra J; Baron F; Sanz J; Spyridonidis A; Savani B; Gluckman E; Nagler A; Mohty M
Transplant Cell Ther; 2022 Oct; 28(10):710.e1-710.e10. PubMed ID: 35830930
[TBL] [Abstract][Full Text] [Related]
9. GVHD occurrence does not reduce AML relapse following PTCy-based haploidentical transplantation: a study from the ALWP of the EBMT.
Baron F; Labopin M; Tischer J; Raiola AM; Vydra J; Blaise D; Chiusolo P; Stölzel F; Fanin R; Chevallier P; Nagler A; Ciceri F; Mohty M
J Hematol Oncol; 2023 Feb; 16(1):10. PubMed ID: 36782226
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow versus peripheral blood as a graft source for haploidentical donor transplantation in adults using post-transplant cyclophosphamide-A systematic review and meta-analysis.
Yu X; Liu L; Xie Z; Dong C; Zhao L; Zhang J; Gu J; Zhu HH
Crit Rev Oncol Hematol; 2019 Jan; 133():120-128. PubMed ID: 30661648
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow versus mobilized peripheral blood stem cell graft in T-cell-replete haploidentical transplantation in acute lymphoblastic leukemia.
Nagler A; Dholaria B; Labopin M; Savani BN; Angelucci E; Koc Y; Arat M; Pioltelli P; Sica S; Gülbas Z; Tischer J; Bernasconi P; Pavlu J; Socié G; Blaise D; Rigacci L; Martino M; Diez-Martin JL; Perić Z; Giebel S; Mohty M
Leukemia; 2020 Oct; 34(10):2766-2775. PubMed ID: 32393841
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia.
Dholaria B; Labopin M; Sanz J; Ruggeri A; Cornelissen J; Labussière-Wallet H; Blaise D; Forcade E; Chevallier P; Grassi A; Zubarovskaya L; Kuball J; Ceballos P; Ciceri F; Baron F; Savani BN; Nagler A; Mohty M
J Hematol Oncol; 2021 May; 14(1):76. PubMed ID: 33941226
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of haploidentical peripheral stem cell transplantation with combination of post-transplant cyclophosphamide (PTCy) and anti-thymocyte globulin (ATG) compared to unrelated donor transplantation in acute myeloid leukemia: A retrospective 10-year experience.
Barkhordar M; Kasaeian A; Janbabai G; Mousavi SA; Fumani HK; Tavakoli S; Bahri T; Ghavamzadeh A; Vaezi M
Leuk Res; 2022 Sep; 120():106918. PubMed ID: 35843087
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic stem cell transplantation for patients with acute myeloid leukemia (AML) in second complete remission (CR2) transplanted from unrelated donors with post-transplant cyclophosphamide (PTCy). A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Nagler A; Labopin M; Swoboda R; Kulagin A; Labussière-Wallet H; Rovira M; Blaise D; Vydra J; Yakoub-Agha I; Choi G; Reményi P; Koc Y; Sanz J; Ciceri F; Mohty M
Bone Marrow Transplant; 2023 May; 58(5):552-557. PubMed ID: 36823454
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Haploidentical Bone Marrow versus Matched Unrelated Donor Peripheral Blood Stem Cell Transplantation with Posttransplant Cyclophosphamide in Patients with Acute Leukemia.
Nagler A; Labopin M; Dholaria B; Angelucci E; Afanasyev B; Cornelissen JJ; Sica S; Meijer E; Ciceri F; Van Gorkom G; Kröger N; Martin H; Pioltelli P; Risitano A; Canaani J; Savani BN; Sanz J; Mohty M
Clin Cancer Res; 2021 Feb; 27(3):843-851. PubMed ID: 33148668
[TBL] [Abstract][Full Text] [Related]
16. Impact of Thymoglobulin by Stem Cell Source (Peripheral Blood Stem Cell or Bone Marrow) After Myeloablative Stem Cell Transplantation From HLA 10/10-Matched Unrelated Donors: A Report From the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
Ravinet A; Cabrespine A; Socié G; Milpied N; Yakoub Agha I; Nguyen S; Michallet M; Menard AL; Maillard N; Mohty M; Suarez F; Huynh A; Marchand T; Deteix C; Cassuto JP; Maury S; Chevallier P; Reman O; Peffault de Latour R; Bay JO
Transplantation; 2016 Aug; 100(8):1732-9. PubMed ID: 26528768
[TBL] [Abstract][Full Text] [Related]
17. Impact of mother donor, peripheral blood stem cells and measurable residual disease on outcomes after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide in children with acute leukaemia.
Rocha V; Arcuri LJ; Seber A; Colturato V; Zecchin VG; Kuwahara C; Nichele S; Gouveia R; Fernandes JF; Macedo AV; Tavares R; Daudt L; De Souza MP; Darrigo-Jr LG; Villela NC; Mariano LCB; Ginani VC; Zanette A; Loth G; Gomes AA; Hamerschlak N; Flowers ME; Bonfim C;
Bone Marrow Transplant; 2021 Dec; 56(12):3042-3048. PubMed ID: 34548627
[TBL] [Abstract][Full Text] [Related]
18. Comparable outcome after haploidentical and HLA-matched allogeneic stem cell transplantation for high-risk acute myeloid leukemia following sequential conditioning-a matched pair analysis.
Doppelhammer M; Fraccaroli A; Prevalsek D; Bücklein V; Häbe S; Schulz C; Hubmann M; Hausmann A; Claus R; Rank A; Schmid C; Tischer J
Ann Hematol; 2019 Mar; 98(3):753-762. PubMed ID: 30617644
[TBL] [Abstract][Full Text] [Related]
19. Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemia.
Nagler A; Kanate AS; Labopin M; Ciceri F; Angelucci E; Koc Y; Gülbas Z; Arcese W; Tischer J; Pioltelli P; Ozdogu H; Afanasyev B; Wu D; Arat M; Peric Z; Giebel S; Savani B; Mohty M
Haematologica; 2021 Jun; 106(6):1591-1598. PubMed ID: 32354866
[TBL] [Abstract][Full Text] [Related]
20. CD34+ cell dose effects on clinical outcomes after T-cell replete haploidentical allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia using peripheral blood stem cells. A study from the acute leukemia working Party of the European Society for blood and marrow transplantation (EBMT).
Maffini E; Labopin M; Blaise D; Ciceri F; Gülbas Z; Deconinck E; Leblond V; Chevallier P; Sociè G; Araujo MC; Koc Y; Savani BN; Gorin NC; Lanza F; Nagler A; Mohty M
Am J Hematol; 2020 Aug; 95(8):892-899. PubMed ID: 32303111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
